Our Advanced Wound Care Specialists Offer the Latest Technology to Accelerate Healing
At Specialty Wound Care, we take a multifaceted approach to wound healing. From testing to treatment, we use the latest available technology to expedite the healing process. Selectively choosing the best partners nationwide allows us to achieve the best outcomes for our patients. Our goal is to provide targeted, individualized treatment to heal wounds as expeditiously as possible and get patients back to their lives.
Our Triple-Layer Allograft is an amniotic membrane allograft derived from a pre-screened mother with a planned C-section delivery. The dehydrated extracellular matrix acts as a scaffold supporting the native tissue. The Triple-Layer Allograft is manufactured in compliance with FDA regulations and AATB guidance.
Our wound testing methods allow the identification of pathogens and sensitivity faster than traditional microbiology, allowing the physician to begin treatment with the correct antibiotic quickly. Traditional culturs may take up to 6 weeks to report fungal pathogens while our lab Wound Panel can detect fungus immediately.
The MolecuLight DX provides informed clinical decision-making; including guiding cleansing, debridement and sampling to regions with high bacterial loads. It also facilitates standard image and video capture as well as digital wound measurement for thorough wound tracking and documentation.
At Specialty Wound Care, we take a multifaceted approach to wound healing. From testing to treatment, we use the latest available technology to expedite the healing process. Selectively choosing the best partners nationwide allows us to achieve the best outcomes for our patients. Our goal is to provide targeted, individualized treatment to heal wounds as expeditiously as possible and get patients back to their lives. Learn More Now.
Amniotic tissue makes up the innermost portion of a woman’s placenta during pregnancy. It consists of amniotic membrane and amniotic fluid. Amniotic membrane is made up of two layers, chorion on the outside and amnion on the inside. The amnion surrounds and contains amniotic fluid. Amniotic fluid surrounds and protects the growing embryo/fetus. Amniotic tissue contains vital nutrients and growth factors that are essential for fetal growth, protection, and healing.
Amniotic tissue collection DOES NOT require fetal sacrifice. The amniotic tissues used in Primus Wound allografts are donated by consenting, healthy women between the ages of 18 – 45 who have just delivered a full-term, healthy baby through elective Cesarean section. A careful medical and social history is collected in advance to ensure donor mothers meet all eligibility requirements. Donor blood samples are collected and thoroughly screened for communicable diseases.
The US Food and Drug Administration (FDA) classifies amniotic tissue as a HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products). An HCT/P is regulated solely under section 361 of the PHS Act and 21 CFR part 1271 if it meets all the following criteria (21 CFR 1271.10(a)): the tissue is minimally manipulated, intended for homologous use and is not combined with other cells or tissues. There can be no systemic effect or dependence on the metabolic activity of living cells to achieve its primary function and the tissue has to have a localized effect in vivo.” If an HCT/P does not meet all of the criteria in 21 CFR 1271.10(a) it will be regulated as a drug, device, and/or biological product and a pre-market review would be required.
Collection of placental tissues causes absolutely no harm to the new born baby or mother. Amniotic tissue, which includes amniotic membrane and amniotic fluid, is taken from the inner most layer of the placenta. The placenta is collected AFTER a live birth delivered via elective cesarean section. The mother has volunteered to donate her placental tissues, which are typically discarded after the birth. Placental / amniotic tissue collection DOES NOT require fetal sacrifice.
COLLECTION Placental tissues are collected at several facilities around the country, following strict guidelines and consistent with industry best practices. At the time of Cesarean delivery (also known as C-section), the baby is delivered and the placenta and amniotic fluid, which are typically discarded, are saved. There is no harm to the new born baby or mother. All tissues are then tested to ensure viability and safety. PROCESSING The collected placental tissues (amniotic membrane and amniotic fluid) are processed to the highest standards in a state-of-the-art American Association of Tissue Banks (AATB) accredited facility. Our process maintains the original characteristics of the amniotic tissue including its cellular components, growth factors, and collagen, and keeps the extracellular matrix intact. This specialized technique results in a graft that maintains the original healing characteristics and protective barrier properties of the amniotic tissue. All processed tissues are tested per USP guidelines prior to release.
Amniotic tissue is a regenerative biofactory, with key components known to optimize the wound healing environment. Its unique make-up: Includes cytokines, amino acids, carbohydrates, hyaluronic acid, and cellular components.¹ Contains key growth factors and extracellular matrix proteins.¹ Offers anti-inflammatory, anti-bacterial, re-epithelialization, and anti-fibrotic properties.² ,³ Has published studies on its benefits and efficacy in wound care dating back over 100 years.4 Mitigates the expression of class II antigens, minimizing immunogenicity and reducing the risk of adverse reaction.⁵
Our goal is to provide targeted, individualized treatment to heal wounds as expeditiously as possible and get patients back to their lives.
